Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
79.74 USD | +0.62% | +0.33% | -3.20% |
Apr. 26 | Medtronic Receives FDA Approval for Inceptiv Spinal Cord Stimulator to Treat Chronic Pain | MT |
Apr. 26 | Medtronic Gets FDA OK for Inceptiv Closed-Loop Spinal Cord Stimulator | DJ |
Evolution of the average Target Price on Medtronic plc
Price target over the last 5 years
History of analyst recommendation changes
Analysts' Consensus
Consensus detail
Consensus revision (last 18 months)
Analysts covering Medtronic plc
Baird | |
UBS | |
Deutsche Bank Securities | |
Mizuho Securities | |
Truist Securities | |
Oppenheimer | |
RBC Capital Markets | |
Morgan Stanley | |
Wells Fargo Securities | |
Stifel Nicolaus | |
CL King | |
Bernstein | |
Evercore ISI | |
Barclays | |
Citigroup | |
Jefferies & Co. | |
Goldman Sachs | |
Piper Sandler | |
Raymond James | |
Wolfe Research | |
Atlantic Equities | |
Cowen | |
JPMorgan Chase | |
Needham & Co. | |
Guggenheim | |
BofA Securities | |
Credit Suisse | |
SVB Leerink | |
BTIG | |
Argus |
EPS Revisions
- Stock Market
- Equities
- MDT Stock
- Consensus Medtronic plc